MI Metagenomi, Inc. Stock: price and insider trades · United States · SEC (Form 4)Track the Metagenomi, Inc. share price and the full directors' dealings record of the company, a listed equity based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Market capitalisation: €44.8m. The latest transaction was disclosed on 8 December 2025 (Cession). Among the most active insiders: Wapnick Pamela. All data is accessible without an account.
€81,191
17 ops.
Sell Volume
Buys €951,077 €81,191 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 8 December 2025
All Executives33 Thresholds0 Prospectus0 Other0
Declarations 33 total
▼ See Remarks · Executives · 5 Dec 2025
199 shares @ US$1.7719 11.8% of flow Common Stock SEC:0001193125-25-310958:0
▼ Chief Financial Officer · Executives · 5 Dec 2025
1,576 shares @ US$1.7719 8.1% of flow Common Stock SEC:0001193125-25-310953:0
▼ Chief Executive Officer · Executives · 5 Dec 2025
1,602 shares @ US$1.7719 16.6% of flow Common Stock SEC:0001193125-25-310937:0
▼ Director · Executives · 5 Dec 2025
3,830 shares @ US$1.7719 22.0% of flow Common Stock SEC:0001193125-25-310971:0
▼ Director · Executives · 5 Sept 2025
2,701 shares @ US$1.81 20.3% of flow Common Stock SEC:0001193125-25-304221:0
▼ Chief Financial Officer · Executives · 5 Sept 2025
1,576 shares @ US$1.81 9.0% of flow Common Stock SEC:0001193125-25-304218:0
▼ Chief Executive Officer · Executives · 5 Sept 2025
1,602 shares @ US$1.81 20.3% of flow Common Stock SEC:0001193125-25-304212:0
▼ See Remarks · Executives · 5 Sept 2025
199 shares @ US$1.81 13.7% of flow Common Stock SEC:0001193125-25-304177:0
▼ See Remarks · Executives · 6 Jun 2025
199 shares @ US$1.75 15.6% of flow Common Stock SEC:0000950170-25-083963:0
▼ Chief Medical Officer · Executives · 6 Jun 2025
5,239 shares @ US$1.75 100.0% of flow Common Stock SEC:0000950170-25-083952:0
▼ Chief Financial Officer · Executives · 6 Jun 2025
1,576 shares @ US$1.75 9.8% of flow Common Stock SEC:0000950170-25-083949:0
▼ Chief Executive Officer · Executives · 6 Jun 2025
10,785 shares @ US$1.75 100.0% of flow Common Stock SEC:0000950170-25-083947:0
▼ See Remarks · Executives · 6 Jun 2025
6,390 shares @ US$1.75 100.0% of flow Common Stock SEC:0000950170-25-083930:0
◆ Chief Executive Officer · Executives · 1 Apr 2025
32,000 shares 0Common Stock SEC:0000950170-25-050102:0
◆ Chief Financial Officer · Executives · 1 Apr 2025
14,000 shares 0Common Stock SEC:0000950170-25-050103:0
◆ See Remarks · Executives · 1 Apr 2025
23,000 shares 0Common Stock SEC:0000950170-25-050101:0
◆ See Remarks · Executives · 1 Apr 2025
3,650 shares 0Common Stock SEC:0000950170-25-050100:0
◆ Chief Medical Officer · Executives · 1 Apr 2025
14,000 shares 0Common Stock SEC:0000950170-25-050098:0
▼ Chief Financial Officer · Executives · 5 Mar 2025
1,808 shares @ US$1.8748 14.4% of flow Common Stock SEC:0000950170-25-035565:0
▼ See Remarks · Executives · 5 Mar 2025
930 shares @ US$1.8748 100.0% of flow Common Stock SEC:0000950170-25-035566:0
▼ Chief Financial Officer · Executives · 5 Dec 2024
1,559 shares @ US$1.86 12.4% of flow Common Stock SEC:0000950170-24-134124:0
▼ Chief Financial Officer · Executives · 5 Sept 2024
6,265 shares @ US$2.88 73.2% of flow Common Stock SEC:0000950170-24-104439:0
◆ See Remarks · Executives · 1 Apr 2024
11,552 shares 0Common Stock SEC:0000950170-24-041515:0
◆ See Remarks · Executives · 1 Apr 2024
6,931 shares 0Common Stock SEC:0000950170-24-041483:0
◆ Chief Scientific Officer · Executives · 1 Apr 2024
69,316 shares 0Common Stock SEC:0000950170-24-041551:0
25 of 33 declarations
Load more (8 remaining) About Metagenomi, Inc. Metagenomi, Inc. is a company focused on developing genetic engineering technologies. It concentrates on therapeutic applications to address genetic diseases.